Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ardizzoni

Showing results (51-60 of 156) with videos related to

Pageof 16
Sort By:
American Journal of Clinical Oncology|October 1, 1987
A phase II study with danazol in metastatic breast cancerP Pronzato, D Amoroso, A Ardizzoni, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|April 1, 1988
[Role of interferon alfa-2 in melanoma. Results of a phase II study in 27 patients]M G Bernengo, G C Doveil, A Appino, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1987
Phase II trials of idarubicin, a new anthracyclineR Rosso, A Ardizzoni, P Conte, et al.
International Journal of Oncology|September 24, 1999
Pre-clinical evaluation of new antineoplastic agents in NSCLC cell lines: evidence of histological subtype-dependent cytotoxicityM Loprevite, R E Favoni, A de Cupis, et al.
International Journal of Oncology|May 6, 2011
Expression of mRNA for gelatinase A and TIMP-2 in cell cultures and tissue samples derived from breast and lung carcinomasG Fassina, G Paglialunga, G Fontanini, et al.
Giornale Italiano Di Chemioterapia|January 1, 1985
[Evaluation of 4-demethoxydaunorubicin toxicity (IMI 30). Preliminary data]M T Nobile, P Pronzato, E Campora, et al.
Haematologica|November 1, 1989
Recombinant alpha interferon in the treatment of low-grade non-Hodgkin's lymphoma: results of a cooperative phase II trial in 31 patientsL Mantovani, C Guglielmi, M Martelli, et al.
Journal of Biological Regulators and Homeostatic Agents|January 27, 2015
Inhibitory effects of different lactobacilli on Candida albicans hyphal formation and biofilm developmentC F Orsi, C Sabia, A Ardizzoni, et al.
International Journal of Cancer|March 15, 1994
Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell linesR E Favoni, A de Cupis, F Ravera, et al.
European Journal of Cancer (Oxford, England : 1990)|May 24, 2003
Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965)R Dziadziuszko, A Ardizzoni, P E Postmus, et al.
Pageof 16

Showing results (51-60 of 156) with videos related to

Sort By:
Pageof 16
American Journal of Clinical Oncology|October 1, 1987
A phase II study with danazol in metastatic breast cancerP Pronzato, D Amoroso, A Ardizzoni, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|April 1, 1988
[Role of interferon alfa-2 in melanoma. Results of a phase II study in 27 patients]M G Bernengo, G C Doveil, A Appino, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1987
Phase II trials of idarubicin, a new anthracyclineR Rosso, A Ardizzoni, P Conte, et al.
International Journal of Oncology|September 24, 1999
Pre-clinical evaluation of new antineoplastic agents in NSCLC cell lines: evidence of histological subtype-dependent cytotoxicityM Loprevite, R E Favoni, A de Cupis, et al.
International Journal of Oncology|May 6, 2011
Expression of mRNA for gelatinase A and TIMP-2 in cell cultures and tissue samples derived from breast and lung carcinomasG Fassina, G Paglialunga, G Fontanini, et al.
Giornale Italiano Di Chemioterapia|January 1, 1985
[Evaluation of 4-demethoxydaunorubicin toxicity (IMI 30). Preliminary data]M T Nobile, P Pronzato, E Campora, et al.
Haematologica|November 1, 1989
Recombinant alpha interferon in the treatment of low-grade non-Hodgkin's lymphoma: results of a cooperative phase II trial in 31 patientsL Mantovani, C Guglielmi, M Martelli, et al.
Journal of Biological Regulators and Homeostatic Agents|January 27, 2015
Inhibitory effects of different lactobacilli on Candida albicans hyphal formation and biofilm developmentC F Orsi, C Sabia, A Ardizzoni, et al.
International Journal of Cancer|March 15, 1994
Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell linesR E Favoni, A de Cupis, F Ravera, et al.
European Journal of Cancer (Oxford, England : 1990)|May 24, 2003
Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965)R Dziadziuszko, A Ardizzoni, P E Postmus, et al.
Pageof 16